ישראל -
עברית -
Ministry of Health
sepacell
"טבע מדיקל (שיווק) בע""מ" - אחות - סינון והרחקת לויקוציטים מתוך מרכיבי דם המיועדים לעירוי
ישראל -
עברית -
Ministry of Health
stiwell med4
כמיטק שיקום בע"מ - מומחה - מערכת סטימולציה להפעלת שרירים במקומות שונים בגוף לאחר פגיעה נוירולוגית
ישראל -
עברית -
Ministry of Health
אוביסטזין פורטה
3m israel - articaine hydrochloride; epinephrine hydrochloride - תמיסה להזרקה - epinephrine hydrochloride 0.012 mg/ml; articaine hydrochloride 40 mg/ml - articaine - articaine - infiltration anesthesia and nerve-block in dentistry. ubistesin is especially indicated for interventions requiring deep anesthesia and pronounced restriction of blood flow such as: - gingival and bone surgery - pulp surgery (amputation and extirpation) - extraction and trepanation of desmotic teeth and extraction of fractured teeth (osteotomy) - protracted surgical procedures i.e. caldwell-luc operation percutaneous osteosynthesis cystectomy mucogingival operations apicectomy.
ישראל -
עברית -
Ministry of Health
אנדוקסן 500 מג זריקה
megapharm ltd - cyclophosphamide - אבקה להכנת תמיסה לזריקה - cyclophosphamide 500 mg/vial - cyclophosphamide - cyclophosphamide - malignant diseases: cycophosphamide although effective alone in susceptible melignancies is more frequently used concurrently or sequentially with other antineoplastic drugs. the following malignancies are often susceptible. cycophosphamide treatment: 1) malignant lymphomas (stages iii and iv of the ann arbor staging system) hodgkin`s disease lymphocytic lymphoma (nodular or diffuse) mixed-cell type lymphoma histiocytic lymphoma burkitt`s lymphoma. 2) multiple myeloma. 3) leukemias: chronic lymphocytic leukemia chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis) acute myelogenous and monocytic leukemia acute lymphoblastic (stemcell) leukemia in children. 4) mycosis fungoides (advenced disease). 5) neuroblastoma (disseminated disease). 6) adenocarcinoma of the ovary. 7) retinoblastoma. 8) carcinoma of the breast. nonmallgnant disease biopsy proven "minimal change" nephrotic syndrome in children whose disease fails to respond adequately to another treatment. severe cases of systemi
ישראל -
עברית -
Ministry of Health
אנדוקסן 1 גרם זריקה
megapharm ltd - cyclophosphamide - אבקה להכנת תמיסה לזריקה - cyclophosphamide 1 g/vial - cyclophosphamide - cyclophosphamide - malignant diseases: cycophosphamide although effective alone in susceptible melignancies is more frequently used concurrently or sequentially with other antineoplastic drugs. the following malignancies are often susceptible. cycophosphamide treatment: 1) malignant lymphomas (stages iii and iv of the ann arbor staging system) hodgkin`s disease lymphocytic lymphoma (nodular or diffuse) mixed-cell type lymphoma histiocytic lymphoma burkitt`s lymphoma. 2) multiple myeloma. 3) leukemias: chronic lymphocytic leukemia chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis) acute myelogenous and monocytic leukemia acute lymphoblastic (stemcell) leukemia in children. 4) mycosis fungoides (advenced disease). 5) neuroblastoma (disseminated disease). 6) adenocarcinoma of the ovary. 7) retinoblastoma. 8) carcinoma of the breast. nonmallgnant disease biopsy proven "minimal change" nephrotic syndrome in children whose disease fails to respond adequately to another treatment. severe cases of systemi